Biotech moot blamed for epidemic spread in US

BOSTON: A biotech meeting at a hotel in downtown Boston appears to be the source of a cluster of the coronavirus in the United States of America and a warning for employers who are still holding big gatherings as the outbreak spread.
Seventy-seven of the 95 confirmed cases in Massachusetts have been linked to a meeting of executives with Biogen, a company based in Cambridge, next to Boston, that develops therapies for neurological diseases, state officials said. An additional 12 people who have tested positive for the virus outside Massachusetts have been linked to the Feb. 26-27 meeting, including five in North Carolina, two in Indiana, and one each in New Jersey, Tennessee and Washington, D.C., officials said. Two tested positive in Europe, Biogen spokesman David Caouette said Wednesday.
The Biogen cluster underscores the danger in continuing to host business gatherings as the virus, which has sickened tens of thousands of people since emerging in China in December, spreads, said Marc Lipsitch, a Harvard University infectious disease epidemiologist.
“We need to stop having meetings like that,” he said, noting a smaller cluster had been linked to a business conference at the Grand Hyatt in Singapore in January. “I think a lot of companies have concluded that on their own.” The Boston conference gathered roughly 175 company executives for two days of meetings at the Marriott Long Wharf hotel, a striking brick landmark on the city’s scenic harborfront.
State health officials say the company notified them of the potential outbreak March 3 and that by March 6 they had publicly confirmed the cases as the type of coronavirus that causes the disease COVID-19. The disease usually exhibits mild or moderate symptoms, such as fever and cough, but it can be worse in older adults and people with other health problems.–Agencies